Source:http://linkedlifedata.com/resource/pubmed/id/12429632
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2002-11-13
|
pubmed:abstractText |
The transforming growth factor alpha-epidermal growth factor receptor (EGFR) autocrine pathway has been implicated in prostate cancer cell growth. Amplification and/or overexpression of c-erbB-2, a receptor closely related to the EGFR, has been recently involved in prostate cancer progression. We investigated EGFR and c-erbB-2 expression in primary androgen-dependent and in advanced androgen-independent prostate cancer and their potential role as markers of disease progression.
|
pubmed:language |
eng
|
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:author |
pubmed-author:AutorinoRiccardoR,
pubmed-author:BiancoA RaffaeleAR,
pubmed-author:CatalanoGiuseppeG,
pubmed-author:CiardielloFortunatoF,
pubmed-author:D'ArmientoFrancesco PFP,
pubmed-author:D'ArmientoMassimoM,
pubmed-author:De LaurentiisMicheleM,
pubmed-author:De PlacidoSabinoS,
pubmed-author:De RosaGaetanoG,
pubmed-author:Di LorenzoGiuseppeG,
pubmed-author:StaibanoStefaniaS,
pubmed-author:TortoraGiampaoloG
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3438-44
|
pubmed:dateRevised |
2009-11-19
|
pubmed:articleTitle |
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
|
pubmed:affiliation |
Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Università degli Studi di Napoli Federico II, 80131 Naples, Italy.
|